Search
Metoxepin
go.drugbank.com/drugs/DB21433ExperimentalThe usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.
Lonodelestat
go.drugbank.com/drugs/DB21452ExperimentalThe usage of the INN stem '-elestat' in the name indicates that Lonodelestat is a elastase inhibitor. Lonodelestat has a monoisotopic molecular weight of 1477.82 Da.
Rizedisben
go.drugbank.com/drugs/DB21610InvestigationalRizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). Rizedisben has a monoisotopic molecular weight of 519.22 Da.
Davelizomib
go.drugbank.com/drugs/DB21660ExperimentalThe usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.
D-1,4-dithiothreitol
go.drugbank.com/drugs/DB02184ExperimentalA reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]
Tabalumab
go.drugbank.com/drugs/DB11657InvestigationalTabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others.
Eprenetapopt
go.drugbank.com/drugs/DB11684InvestigationalEprenetapopt has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms, and Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
Opiranserin
go.drugbank.com/drugs/DB16271InvestigationalOpiranserin is under investigation in clinical trial NCT03997838 (Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-operative Pain Following Abdominoplasty).
Pegylated Recombinant Human Arginase I
go.drugbank.com/drugs/DB16282InvestigationalPegylated Recombinant Human Arginase I is under investigation in clinical trial NCT03455140 (A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)).
XmAb24306
go.drugbank.com/drugs/DB17526InvestigationalXmAb24306 is an investigational cancer immunotherapy. It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.